Overcoming the technical, logistical and translational challenges of delivering meaningful clinical efficacy with radionuclide therapies
Welcome to Targeted Radiopharmaceuticals (TRP) Summit, the industry-led forum designed to accelerate the development of next-generation radiopharmaceuticals. The faculty of expert speakers will lead us through a comprehensive discussion of the challenges & opportunities currently facing this space as it undergoes an exciting resurgence.
We have been working with companies including: Endocyte, MTR, Actinium Pharmaceuticals, Tagworks, Bayer & Roche, to assemble this agenda. The key focus of which will be exploring how to advance the therapeutic potential of radiation. The important role of diagnostic imaging is also key to providing a truly well-rounded conference in this field. As such, fully appreciating the potential that combinations of theranostics & diagnostics offer will be integral throughout.
The main areas of focus include:
- Identifying & Assessing the Therapeutic Potential of Novel Targets
- Updates on the New Regulatory Hurdles in the US & EU
- Optimising Chemical Modification Methods & Combination Rationale - Radioimmunotherapy and Beyond
View full event guide for more information.
"Overall great conference with a combination of excellent speakers and focused, relevant content. A Good balance of technical and business driven talks."
Eisai, Past Hanson Wade Attendee
“I thought the conference was very focused. It was time well spent. I learned a lot and had productive networking sessions.”
Genentech, Past Hanson Wade Attendee
"A good meeting in terms of presentation topics, interactive workshop"
Celgene, Past Hanson Wade Attendee
Key Benefits of Attending:
Hear from Expert Speakers including:
Vice President of Research
Head of Nuclear Medicine & Imaging
Research Group Leader at Paul Scherrer Institute and Private Docent
Chief Scientific Officer
Proud to Partner With: